We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
This significant outperformance reflects TACT’s continued success in expanding its product offerings, securing high-value deals and maintaining robust financial growth. With such impressive gains already on the board, the question remains — Should investors buy, sell or hold the stock now?
TransAct Expands Its Market Share With BOHA
TransAct is riding on the back of its food service technology business where it is making strides with BOHA Terminal 2. The device is an international success with TACT, adding 13 new customers with the BOHA Terminal 2 in the second quarter of 2024. TransAct is expecting 3,500 units of BOHA Terminal 2 to be sold in the remaining part of 2024.
BOHA Terminal 2 offers customers compliance with the Food and Drug Administration, making this a unique selling point of the device. TACT is receiving positive feedback from both existing and prospective customers, with many existing customers upgrading to BOHA Terminal 2 from the older AccuDate and original BOHA terminals.
The BOHA platform is entering new markets where customers are appreciating its unique offerings and cost savings. This is also reflected in TACT’s revenues. In the second quarter of 2024, TransAct Technologies reported revenues of $11.6 million, which increased 9% sequentially.
TransAct Technologies 3 Month Performance
Image Source: Zacks Investment Research
TransAct Fares Well Against Competition
TransAct faces stiff competition in all of its end markets. However, competition in the Casino and Gaming market and POS automation has seen a surge due to the re-entry of major competitors. In both the end markets, TransAct’s competitors have been using a price competition strategy to gain market share, causing TACT to lose 40% of sales in the second quarter in POS automation alone.
TACT’s existing competitors in POS Automation include Epson, Star Micronics and Citizen. Casino and Gambling market competitors are JCM Global, Nanoptix, Inc., Custom Engineering SPA and Eurocoin. Food technology service competitors are Digi International Inc. (DGII - Free Report) , Avery Dennison Corporation (AVY - Free Report) and Ecolab Inc. (ECL - Free Report) .
Digi International provides a range of IoT products ranging from Packaging and sorting equipment, food safety equipment like DigiSense, weigh-wrap labelers and many more. On the other hand, Avery Dennison and Ecolab provide solutions, including labeling and food safety solutions. Most of these competitors have greater resources than TACT.
To counter the existing and new competition in these end markets, TransAct is adjusting its prices to maintain its market share. TransAct is also focusing on improving its food service technology business when its other businesses are suffering. With the launch of innovative products like BOHA Terminal 2, TACT is maintaining a high growth rate in the food service technology annual recurring revenues. In the second quarter of 2024, food service technology recurring revenues were up 12% year over year.
Here's What Investors Should Do
Given the bright prospects of its food service technology business and recovery in other segments, TACT is poised to grow in the future. TransAct has a Value Style score of A, reflecting that the stock is fairly valued. We recommend investors to buy this Zacks Rank #2 (Buy) stock at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
TransAct Rises 16% in 3 Months: How Should Investors Play the Stock?
TransAct Technologies (TACT - Free Report) shares have gained 15.9% in the past three months, outperforming the Zacks Computer and Technology sector, the Zacks Computer - peripheral Equipment industry and the S&P 500 index.
This significant outperformance reflects TACT’s continued success in expanding its product offerings, securing high-value deals and maintaining robust financial growth. With such impressive gains already on the board, the question remains — Should investors buy, sell or hold the stock now?
TransAct Expands Its Market Share With BOHA
TransAct is riding on the back of its food service technology business where it is making strides with BOHA Terminal 2. The device is an international success with TACT, adding 13 new customers with the BOHA Terminal 2 in the second quarter of 2024. TransAct is expecting 3,500 units of BOHA Terminal 2 to be sold in the remaining part of 2024.
BOHA Terminal 2 offers customers compliance with the Food and Drug Administration, making this a unique selling point of the device. TACT is receiving positive feedback from both existing and prospective customers, with many existing customers upgrading to BOHA Terminal 2 from the older AccuDate and original BOHA terminals.
The BOHA platform is entering new markets where customers are appreciating its unique offerings and cost savings. This is also reflected in TACT’s revenues. In the second quarter of 2024, TransAct Technologies reported revenues of $11.6 million, which increased 9% sequentially.
TransAct Technologies 3 Month Performance
Image Source: Zacks Investment Research
TransAct Fares Well Against Competition
TransAct faces stiff competition in all of its end markets. However, competition in the Casino and Gaming market and POS automation has seen a surge due to the re-entry of major competitors. In both the end markets, TransAct’s competitors have been using a price competition strategy to gain market share, causing TACT to lose 40% of sales in the second quarter in POS automation alone.
TACT’s existing competitors in POS Automation include Epson, Star Micronics and Citizen. Casino and Gambling market competitors are JCM Global, Nanoptix, Inc., Custom Engineering SPA and Eurocoin. Food technology service competitors are Digi International Inc. (DGII - Free Report) , Avery Dennison Corporation (AVY - Free Report) and Ecolab Inc. (ECL - Free Report) .
Digi International provides a range of IoT products ranging from Packaging and sorting equipment, food safety equipment like DigiSense, weigh-wrap labelers and many more. On the other hand, Avery Dennison and Ecolab provide solutions, including labeling and food safety solutions. Most of these competitors have greater resources than TACT.
To counter the existing and new competition in these end markets, TransAct is adjusting its prices to maintain its market share. TransAct is also focusing on improving its food service technology business when its other businesses are suffering. With the launch of innovative products like BOHA Terminal 2, TACT is maintaining a high growth rate in the food service technology annual recurring revenues. In the second quarter of 2024, food service technology recurring revenues were up 12% year over year.
Here's What Investors Should Do
Given the bright prospects of its food service technology business and recovery in other segments, TACT is poised to grow in the future. TransAct has a Value Style score of A, reflecting that the stock is fairly valued. We recommend investors to buy this Zacks Rank #2 (Buy) stock at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.